Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05494385 · ClinicalTrials.gov registry record · Phase 4
Effect of Perioperative Gabapentin on Postoperative Opioid Requirements
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 114
- Enrollment target
NCT05494385 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 114 participants.
The verdict
NCT05494385, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if preoperative gabapentin is noninferior to preoperative and postoperative gabapentin for pain control in patients undergoing surgery for pelvic organ prolapse.
Interventions
- DRUG Preoperative Gabapentin/Postoperative Placebo
- DRUG Preoperative Gabapentin/Postoperative Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2023-07-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05494385
The ClinicalTrials.gov registry entry for NCT05494385 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Preoperative Gabapentin/Postoperative Placebo is the first listed.
NCT05494385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05494385 about?
NCT05494385 is a clinical study titled "Effect of Perioperative Gabapentin on Postoperative Opioid Requirements". The purpose of this study is to determine if preoperative gabapentin is noninferior to preoperative and postoperative gabapentin for pain control in patients undergoing surgery for pelvic organ prolapse.
What is the current status of trial NCT05494385?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 114 participants. The study started on 2021-07-27. Estimated completion is 2023-07-05.
What interventions are being tested in trial NCT05494385?
The interventions under investigation include: Preoperative Gabapentin/Postoperative Placebo (DRUG), Preoperative Gabapentin/Postoperative Gabapentin (DRUG).
Who is sponsoring clinical trial NCT05494385?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.